Gene · 5629
Papers3,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer. | Drug Resist Updat | 2025 | 40706422 | PubTator, text mining | PubMed |
| Case Report: Surgical management of primary lymphedema with a novel PROX1 mutation involving upper and lower limbs. | Front Genet | 2025 | 40678385 | PubTator, text mining | PubMed |
| Prognostic relevance of prospero homeobox 1 and metastasis tumor antigen 1 in patients with malignant salivary gland tumors: a clinicopathological study. | Eur J Med Res | 2025 | 40660330 | PubTator, text mining | PubMed |
| Extracellular vesicle-mediated transmission of circPDLIM5 promotes lymphatic metastasis in prostate cancer. | J Exp Clin Cancer Res | 2025 | 40611320 | PubTator, text mining | PubMed |
| MS275 Inhibits Neuroblastoma Cell Growth by Mediating H3K27ac/PROX1 Axis In Silico and In Vitro. | FASEB J | 2025 | 40601211 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing: new insights for pulmonary endothelial cells. | Front Cell Dev Biol | 2025 | 40599812 | PubTator, text mining | PubMed |
| CRY2 (rs11605924) and G6PC2 (rs560887) single nucleotide polymorphisms increase risk of type 2 diabetes mellitus. | Biomed Rep | 2025 | 40599617 | PubTator, text mining | PubMed |
| Transcription factor CREB1 promotes malignant growth of osteosarcoma cells by inhibiting miRNA-183-5p and regulating PROX1 expression. | Mol Biol Rep | 2025 | 40579642 | PubTator, text mining | PubMed |
| DTL dose-dependent control of sex-dimorphic ferroptosis in liver ischemia reperfusion injury. | Cell Rep | 2025 | 40560731 | PubTator, text mining | PubMed |
| PROX1 is an early driver of lineage plasticity in prostate cancer. | J Clin Invest | 2025 | 40454483 | PubTator, text mining | PubMed |
| Unveiling the dynamic drivers: phase separation's pivotal role in stem cell biology and therapeutic potential. | Stem Cell Res Ther | 2025 | 40442783 | PubTator, text mining | PubMed |
| LNCAROD was stabilized through N6-methyladenosine methylation and exerted its anticancer effects in lung squamous cell carcinoma by inhibiting SIRT1 activity via CCAR2. | Transl Lung Cancer Res | 2025 | 40386722 | PubTator, text mining | PubMed |
| Angiogenesis related gene signatures predict prognosis and guide therapeutic strategies in renal clear cell carcinoma. | Sci Rep | 2025 | 40379825 | PubTator, text mining | PubMed |
| Border-associated macrophages as gatekeepers of brain homeostasis and immunity. | Immunity | 2025 | 40324381 | PubTator, text mining | PubMed |
| Prox1 Protein in Corneal Limbal Lymphatic Vessels Maintains Limbal Stem Cell Stemness and Regulates Corneal Injury Repair. | Invest Ophthalmol Vis Sci | 2025 | 40298888 | PubTator, text mining | PubMed |
| Differential biomarker expression of blood and lymphatic vasculature in multi-organ-chips. | Sci Rep | 2025 | 40281034 | PubTator, text mining | PubMed |
| Prognostic Impact of Immunophenotypic Variation in Subcapsular Sinus Endothelium of Sentinel Lymph Nodes in Invasive Breast Carcinoma. | Breast Care (Basel) | 2025 | 40256677 | PubTator, text mining | PubMed |
| Changes in vascular identity during vascular remodeling. | JVS Vasc Sci | 2025 | 40213096 | PubTator, text mining | PubMed |
| PROX1: A Key Regulator of Hepatocyte Identity and Tumorigenesis. | Cancer Res | 2025 | 40163354 | PubTator, text mining | PubMed |
| Bioprinted Hydrogels as Vehicles for the Application of Extracellular Vesicles in Regenerative Medicine. | Gels | 2025 | 40136896 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5629/papers?page=6